None listed
Conditions
Brief summary
This study aims to assess whether the side of the body that a central venous line is inserted affects the risk of developing a bloodstream infection in cancer patients. Who is it for? You may be eligible to join this study if you are a cancer patient aged 15 years or above, who needs to have a central venous access device (CVAD) inserted. Trial details Participants in this trial will be randomly (by chance) allocated to one of two groups. Participants in one group will have the CVAD inserted into their dominant arm (i.e. right arm in right-handed people and left arm in left-handed people). Participants in the other group will have the CVAD inserted into their non-dominant arm. There will be no other change to treatment provided. Participants will be monitored to determine the incidence of catheter-associated bloodstream infection (CA-BSI) and catheter-related bloodstream infection (CR-BSI). This will enable us to find out whether the increased movement of the dominant arm might increase the risk of infection.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
1. Provision of informed consent 2. Inpatients or outpatients with cancer who need to have a CVAD inserted
Exclusion criteria
1. Contraindication to CVAD insertion on one side of the body. This may include: * patients with breast cancer where there is a preference to insert CVADs in a particular side * prior line related thrombosis where there is a preference to insert CVADs in a particular side * prior difficult line insertion where there is a preference to insert CVADs in a particular side * any other medical reason where the patient’s physician or interventional radiologist believes that insertion on one side is contraindicated 2. Implantable ports will not be included in the study 3. Peripheral venous catheters are excluded